Nerimo klinika - Company finances
|
EUR
|
2018
From: 2018-01-01
To: 2018-12-31
|
2019
From: 2019-01-01
To: 2019-12-31
|
2020
From: 2020-01-01
To: 2020-12-31
|
2021
From: 2021-01-01
To: 2021-12-31
|
2022
From: 2022-01-01
To: 2022-12-31
|
2023
From: 2023-01-01
To: 2023-12-31
|
2024
From: 2024-01-01
To: 2024-12-31
|
2025
From: 2025-02-01
To: 2026-01-31
|
|---|---|---|---|---|---|---|---|---|
|
Financial data
|
||||||||
| Sales revenue | - | 7,860 | 24,915 | 48,938 | 35,979 | 39,422 | 36,567 | 36,732 |
| Profit before tax | - | - | - | - | -2,312 | -374 | 418 | -519 |
| Net profit | - | - | - | - | -2,312 | -374 | 395 | -519 |
| Equity | 283 | -12,394 | -253 | 1,652 | -660 | -1,034 | -638 | -1,156 |
| Liabilities | 0 | 15,015 | 5,307 | 6,198 | 5,937 | 6,104 | 6,304 | 6,973 |
| Non-current assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current assets | 18,221 | 2,621 | 5,054 | 7,850 | 5,277 | 5,125 | 5,966 | 6,117 |
| Total assets | 18,221 | 2,621 | 5,054 | 7,850 | 5,277 | 5,125 | 5,966 | 6,117 |
|
Taxes paid
|
||||||||
| STI taxes | - | - | - | - | - | 3,187 | 2,568 | 2,428 |
|
Financial indicators
|
||||||||
| Revenue change y/y | - | - | +217.0% | +96.4% | -26.5% | +9.6% | -7.2% | +0.5% |
| ROA Return on Assets (ROA). The ratio of net profit to assets. Indicates the company's efficiency. | - | - | - | - | -43.8% | -7.3% | 6.6% | -8.5% |
| ROE Return on equity. The ratio of net profit to equity. Shows the return to shareholders. | - | - | - | - | - | - | - | - |
| Profit margin Net profit margin. Shows the overall profitability of the company. | - | - | - | - | -6.4% | -0.9% | 1.1% | -1.4% |
| EBT% EBT (Earnings Before Taxes) to revenue ratio. Shows the overall profitability of the company. | - | - | - | - | -6.4% | -0.9% | 1.1% | -1.4% |
| Liabilities/Equity The debt-to-equity ratio shows the company's capital structure. | - | - | - | 3.8 | - | - | - | - |
| Revenue per employee Ratio of revenue to the average annual number of employees. Indicates company efficiency. | - | 7,860 | 24,915 | 48,938 | 35,979 | 39,422 | 36,567 | 36,732 |
Sales revenue
See Scoris data in Google Search
Mark Scoris as a favorite source. One click, no registration.
Nerimo klinika - Social security debts
| From | To | Debt, € |
|---|---|---|
| 2026-05-03 | 2026-05-13 | 1.04 |
| 2026-04-24 | 2026-04-29 | 1.04 |
| 2026-02-18 | 2026-02-22 | 335.27 |
| 2026-01-16 | 2026-01-20 | 335.27 |
| 2025-07-24 | 2025-08-05 | 0.36 |
| 2025-05-16 | 2025-05-18 | 334.90 |
| 2025-02-10 | 2025-02-10 | 0.63 |
| 2025-01-22 | 2025-02-05 | 0.63 |
| 2024-11-18 | 2024-11-21 | 335.27 |
| 2023-10-25 | 2023-11-05 | 1.56 |
| 2023-08-17 | 2023-08-31 | 335.27 |
Nerimo klinika - VMI tax arrears
As of 2026-09-02, the amount of overdue STI tax debt of the company Nerimo klinika is: 6 €
| From | To | Overdue, € |
|---|---|---|
| 2026-09-01 | 2026-09-02 | 6.0 |
| 2026-08-31 | 2026-08-31 | 5.64 |
| 2026-08-19 | 2026-08-30 | 4.2 |
| 2026-08-05 | 2026-08-18 | 0.02 |
| 2026-08-02 | 2026-08-04 | 4.2 |
| 2026-07-01 | 2026-08-01 | 1.5 |
| 2026-06-30 | 2026-06-30 | 0.6 |
| 2026-06-03 | 2026-06-29 | 0.02 |
| 2026-06-01 | 2026-06-02 | 6.16 |
| 2026-05-31 | 2026-05-31 | 4.9 |
| 2026-05-01 | 2026-05-30 | 3.7 |
| 2026-04-30 | 2026-04-30 | 3.14 |
| 2026-04-01 | 2026-04-29 | 1.94 |
| 2026-03-20 | 2026-03-31 | 0.26 |
| 2026-03-12 | 2026-03-19 | 0.24 |
| 2026-01-20 | 2026-03-08 | 0.26 |
| 2026-01-09 | 2026-01-19 | 206.31 |
| 2025-06-19 | 2026-01-08 | 0.02 |
| 2025-05-06 | 2025-05-19 | 0.33 |
| 2024-12-31 | 2025-02-06 | 0.33 |
VMI debt information has been collected since 2024-10-07. Debts for older periods will not be displayed.
Analysis of the company's financial position
This description was generated by artificial intelligence.
Report if inaccurate.
Nerimo klinika, VšI (code 304458507) is a Public Institution operating in medical specialists activities. In 2025, the company generated revenue of EUR 36.7K, broadly in line with 2024 revenue of EUR 36.6K and below the EUR 39.4K achieved in 2023. Profitability weakened again in 2025, with net loss of EUR 519 after a net profit of EUR 395 in 2024 and a net loss of EUR 374 in 2023. The 2025 profit margin was -1.4%, indicating a small loss on a relatively stable turnover base. Over the two-year period, revenue declined by 6.8%, while the latest year showed only 0.5% growth. The balance sheet remained small, with total assets of EUR 6.1K and liabilities of EUR 7.0K at the end of 2025, leaving equity at negative EUR 1.2K. Asset turnover was 6.00x, reflecting a high level of revenue relative to the asset base. Revenue per employee in 2025 was EUR 36.7K, while profit per employee was EUR -519.